Biodexa Pharmaceuticals (BDRX)

AI Score

Unlock

1.44

-0.10 (-6.49%)

At close: Apr 03, 2025, 3:59 PM

1.46

1.29%

After-hours: Apr 03, 2025, 07:58 PM EDT

Biodexa Pharmaceuticals Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Revenue	381K	699K	578K	343K	674K	1.94M	989K	1.32M	1.38M	157K	147K	n/a
Cost of Revenue	4.07M	5.11M	4.65M	6.07M	7.84M	9.36M	8.33M	7.73M	70K	n/a	n/a	n/a
Gross Profit	-3.69M	-4.41M	-4.08M	-5.72M	-7.17M	-7.42M	-7.34M	-6.41M	1.3M	157K	147K	n/a
Operating Income	-8.01M	-8.93M	-7M	-10.67M	-11.32M	-11.81M	-11.78M	-9.65M	-10.09M	-7.71M	-4.5M	-4.01M
Interest Income	83K	24K	44K	33K	89K	585K	94K	91K	48K	153K	384K	557K
Pretax Income	-7.49M	-8.49M	-6.11M	-23.47M	-10.92M	-12.4M	-12.97M	-8.39M	-11.23M	-9.84M	-4.88M	-4.57M
Net Income	-7.08M	-7.66M	-5.46M	-22.19M	-9.14M	-10.37M	-11.71M	-6.16M	-10.1M	-8.82M	-4.08M	-3.99M
Selling & General & Admin	4.34M	4.54M	2.95M	4.96M	4.16M	4.39M	4.44M	3.25M	2.69M	4.23M	1.81M	2.36M
Research & Development	4.07M	5.11M	4.65M	16.15M	7.84M	9.36M	9.83M	7.73M	8.71M	5.44M	2.84M	1.65M
Other Expenses	-4.08M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	4.33M	4.05M	1.99M	17.71M	3.67M	4.39M	5.54M	2.07M	12.59M	9.84M	4.65M	4.01M
Interest Expense	41K	53K	44K	34K	97K	587K	109K	n/a	n/a	161K	248K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	6K	323K	n/a	170K	n/a	605K	n/a	n/a	n/a
Cost & Expenses	8.39M	9.16M	6.64M	23.78M	11.51M	13.75M	13.87M	9.8M	12.65M	9.84M	4.65M	4.01M
Income Tax Expense	-406K	832K	646K	1.28M	1.78M	2.03M	1.26M	2.23M	1.13M	1.02M	799K	571K
Shares Outstanding (Basic)	31.59K	12.35K	10.07K	5.36K	2.29K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Diluted)	31.59K	12.35K	10.07K	5.36K	2.29K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EPS (Basic)	-224.13	-619.72	-542.31	-4.14K	-3.99K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EPS (Diluted)	-224.13	-619.72	-542.31	-4.14K	-3.99K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA	-7.16M	-7.39M	-5.66M	-22.22M	-9.54M	-10.7M	-10.61M	-5.3M	-10.49M	-9.36M	-4.25M	-3.81M
EBIT	-7.44M	-8.44M	-6.06M	-23.44M	-10.83M	-11.81M	-12.86M	-8.31M	-11.23M	-9.68M	-4.63M	n/a
Depreciation & Amortization	283K	343K	403K	1.22M	1.28M	1.11M	1.17M	4.35M	736K	321K	246K	194K